NCT01493180 - Exploratory Study of OPC-12759 Ophthalmic Suspension | Biotech Hunter

Enrollment

102

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

November 30, 2012

Study Completion Date

December 31, 2012

Conditions

Keratoconjunctival Epithelial Disorder

Interventions

DRUG

OPC-12759 ophthalmic suspension

OPC-12759 ophthalmic suspension 2%

DRUG

Sodium hyaluronate ophthalmic solution

Sodium hyaluronate ophthalmic solution 0.1%

Trial Locations (10)

Kanto region, Hachiōji

Kansai region, Ibaraki

Kansai region, Ikoma

Kansai Region, Kobe

Chugoku region, Kure

Kansai region, Kyoto

Tokai region, Nagoya

Kansai region, Osaka

Kansai region, Sayama

Kanto region, Tokyo